VR kitten game aims to boost aging brains
NCT ID NCT07183033
First seen Jun 26, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This small study tests whether a virtual reality exercise program called 'Kitten Crossing the Bridge' can improve brain flexibility in older adults with cognitive frailty. Fifteen participants will do VR-based leg exercises twice a week for four weeks. Researchers will measure brain activity and thinking skills to see if the training helps.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- VR-based resistance training program (Kitten Crossing the Bridge)
- What this could lead to
- If it works, this could point toward a non-drug way to improve brain function in older adults with mild thinking problems.
- What could go wrong
- This is a very small, early exploratory trial with only 15 participants and no control group. Results may not apply to everyone, and the VR program may not show clear benefits.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 15 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jul 2025
- Expected to finish
-
Dec 2025
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
60 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Frailty Phenotype (FP) score between 1 and 5 * Subjective Cognitive Decline Questionnaire (SCD-Q9) score ≥ 5 * Montreal Cognitive Assessment (MoCA) score between 15 and 25 * Activities of Daily Living (ADL) score ≤ 26 * Age ≥ 60 years * Submit written informed consent prior to participating in the study Exclusion Criteria: * Clinical diagnosis of Alzheimer's disease, other dementias, or neuropsychiatric disorders (e.g., cerebrovascular disease, Parkinson's disease, history of traumatic brain injury, brain tumors, epilepsy) * Current use of medications or addictive substances that may impair cognition * Presence of musculoskeletal disorders (e.g., osteoarthritis, fractures), cardiovascular disease, or liver/kidney dysfunction that prevent safe participation in exercise * Severe sensory or speech impairments that hinder communication * Severe motion sickness or vestibular disorders
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Cognitive frailty are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
The full official record for this study. This one lists no contact details, but it is the first place any would appear.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
School of Nursing, Chinese Academy of Medical Sciences & Peking Union Medical College
Beijing, Beijing Municipality, 100144, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.